mined whether evidence-based recommendations have been incorporated into current emergency medical services (EMS) system protocols.
Methods | Treatment protocols for adult patients presenting with seizures from 33 EMS systems covering the 58 counties in California were accessed online and reviewed by 2 of the authors (J.P.B. and E.L.G.) between May and June 2018 without disagreements. The protocols were reviewed to determine (1) when they were last updated in relation to the prehospital treatment studies and 2016 guideline and (2) whether generalized convulsive status epilepticus was defined in strict accordance with the definition referenced in the guidelines (≥5 minutes of continuous seizure or ≥2 discrete seizures between which there is incomplete recovery of consciousness). 3, 4 We determined if any of the 3 studied benzodiazepines were included in the protocols along with the route of administration and dose. In an effort to be inclusive, we compared the EMS system protocols with the range of doses studied in the randomized clinical trials, which were incorporated into the guideline recommendations, recognizing that some EMS system protocols have not been updated since the 2016 guideline was published and may have based their dosing from clinical trial data.
Results | The most recent revision date for the protocols from the 33 EMS systems ranged from 2007 to 2018 with 27 (81.8%) revised after publication of the second clinical trial in 2012 and 17 (51.5%) revised after publication of the guideline in 2016 (Table) . Seven EMS system protocols (21.2%) defined generalized convulsive status epilepticus according to published guidelines. Thirty-two EMS system protocols (97.0%) included intramuscular midazolam; 2 (6.1%), intravenous lorazepam; and 5 (15.2%), intravenous diazepam.
Thirty-two EMS system protocols (97.0%) listed intravenous midazolam and 16 (48.5%) listed intraosseous midazolam as options. Two EMS system protocols recommended an initial dose of intramuscular midazolam of 10 mg in accordance with clinical trial data, whereas 30 recommended a lower initial dose. Both of the protocols that included intravenous lorazepam recommended doses in accordance with trial data (2-4 mg).
Two of 5 EMS system protocols that included diazepam recommended a dose in agreement with trial data or published guidelines (5-10 mg). Six EMS system protocols (18.2%) recommended at least 1 of the medications by the route and dose suggested in the trials or in the guidelines.
Discussion | California EMS system protocols varied widely with regard to the definition and treatment of generalized convulsive status epilepticus. Many protocols did not follow evidencebased guidelines and did not accurately define generalized convulsive status epilepticus.
Although intramuscular midazolam was appropriately emphasized in the protocols, the dose was often lower than recommended. Most protocols listed intravenous and intraosseous midazolam as options, which were not studied in the randomized clinical trials or recommended in the guideline. Appropriate dosing and route of administration is critical in achieving timely cessation of generalized convulsive status epilepticus.
This study underscores the challenge of translating evidence to implementation in the prehospital setting. Why EMS system protocols deviate from the evidence and how this affects patient outcomes deserve further study.
5
Potential reasons for not incorporating current evidence include difficulty transferring information from trials or guidelines to protocols, systematic issues updating EMS system protocols, coordination of stakeholder organizations, and limited awareness about the harm of insufficient benzodiazepine dosing.
6 An initial step would be to ensure EMS system protocols differentiate between a seizure and generalized convulsive status epilepticus and that the definition is standardized across protocols. Limitations of the study include investigation of EMS system protocols from a single state and protocols may not necessarily reflect what emergency medical technicians actually do in practice. Emergency medical services systems were not contacted for their most updated protocols; rather, the most recent protocol available on each system's website was used. 
COMMENT & RESPONSE

Race and Ethnicity Data in Research
To the Editor Mr Bonham and colleagues 1 cautioned about using race and ethnicity in genomic research to make predictions about individuals, populations, and clinical outcomes. We agree with their call for consensus in the research uses of race and ethnicity and that "other types of data providing more nuanced insights should be collected in addition to race, ethnicity, and genetic ancestry, such as a person's educational attainment, income, and geographic residence." Even though national attention has drifted toward understanding race, ethnicity, and health with genomics, health services research methods for studying race and ethnicity have stayed stagnant in recent decades, largely using surveys developed in the mid-20th century, failing to properly use data innovations in health systems and, therefore, not uncovering the nuance for which these authors called.
A path toward better understanding of race and ethnicity and their association with health relies on the potential to increasingly employ and link novel data sets, which may have yet to be fully used for research in race and ethnicity. For example, national electronic health record data sets have provided insights on racial and ethnic disparities in preventive services 2 and have been used to study disparities in Medicaid coverage accuracy when linked to claims.
3
In addition, there is burgeoning evidence that zip code is a better predictor of life expectancy than genetic code. 4 The capacity now exists to link large patient data sets by patient address to numerous community-level social determinants of health to understand the intersection between social determinants and race and ethnicity. 
